Owner Ace ApS

Inventors Bonnichsen, Richard

Agent Peter Maxwell & Associates

Pub. Number AU-B-2005274574

PCT Pub. Number WO2006/018024

Priority PA 2004 01247 18.08.04 DK; 60/607,919 08.09.04 US

Filing date 18 August 2005

Wipo publication date 23 February 2006

Acceptance publication date 17 March 2011

A61K 31/198 (2006.01)

A61K 31/401 (2006.01) - Proline

A61K 31/404 (2006.01)

A61K 31/41 (2006.01) - having five-membered rings with two or more ring hetero atoms, at least one of which is nitrogen, e.g. tetrazole

A61K 31/4164 (2006.01) - 1,3-Diazoles

A61K 31/4166 (2006.01)

A61K 31/4174 (2006.01)

A61K 31/4178 (2006.01)

A61K 31/4184 (2006.01)

A61K 31/4245 (2006.01) - Oxadiazoles

A61K 31/47 (2006.01) - Quinolines

A61K 31/472 (2006.01) - Non-condensed isoquinolines, e.g. papaverine

A61K 31/502 (2006.01) - ortho- or peri-condensed with carbocyclic ring systems, e.g. cinnoline, phthalazine

A61K 31/554 (2006.01) - having at least one nitrogen and at least one sulfur as ring hetero atoms, e.g. clothiapine, diltiazem

A61K 38/05 (2006.01) Medicinal preparations containing peptides - Dipeptides

A61K 38/06 (2006.01) Medicinal preparations containing peptides - Tripeptides

A61K 38/08 (2006.01) Medicinal preparations containing peptides - Peptides having 5 to 11 amino acids

A61P 17/00 (2006.01) Drugs for dermatological disorders